Apr 16, 2025

News & Events
Press Releases
Mar 26, 2025
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
Mar 24, 2025
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Feb 3, 2025
Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
Events
11th Annual Tumor Models Conference
EHA 2023 Hybrid Congress
BIO International Convention
AACR ANNUAL MEETING 2023
In the News
Precision Medicine Online